Charles B. O'Keeffe, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 5,000 shares at $2.30 ($12K) on 2015-11-19, disclosed to the SEC on 2015-11-19.
Seasonal purchase ($12k) by Director — this insider has traded CPRX in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CPRX | BUY | 2019-10-11 | $47K | — | Filing → |
| CPRX | BUY | 2018-12-14 | $50K | — | Filing → |
| CPRX | BUY | 2018-06-08 | $3K | — | Filing → |